A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China
Clinical trial NCT05576792 · COMPLETED
Trial details
- NCT number
- NCT05576792
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-13
- Primary completion
- 2024-07-10
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.